Kiora Pharmaceuticals Inc...
(KPRX)
undefined
undefined%
At close: undefined
3.32
0.61%
After-hours Dec 13, 2024, 03:59 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Cash & Equivalents | 2.45M | 5.96M | 7.85M | 1.19M | 3.78M | 8.00M | 7.81M | 3.64M | 8.39M | 167.00K | 501.17K | 1.97M |
Short-Term Investments | - | - | - | - | - | - | - | - | - | - | - | - |
Long-Term Investments | - | 49.26K | 45.00K | 45.00K | 45.00K | 45.00K | 45.00K | 103.82K | 78.82K | - | - | - |
Other Long-Term Assets | 45.03K | 82.26K | 87.96K | 102.07K | 114.40K | 76.71K | 352.13K | 100.31K | -20.24K | 1.19M | 130.57K | 281.28K |
Receivables | 2.05M | 1.37M | 529.56K | 90.97K | 4.86K | 18.44K | 23.68K | 53.83K | 932.59K | 25.34K | 35.12K | 38.72K |
Inventory | - | - | - | - | - | - | - | - | - | - | - | - |
Other Current Assets | 233.38K | 343.07K | 1.21M | 449.57K | 1.00M | 911.52K | 1.26M | 464.98K | 122.39K | 52.89K | 22.35K | 41.11K |
Total Current Assets | 4.74M | 7.68M | 8.99M | 1.81M | 4.32M | 8.48M | 8.46M | 4.15M | 9.45M | 218.78K | 558.65K | 2.05M |
Property-Plant & Equipment | 114.95K | 172.17K | 283.41K | 30.57K | 16.85K | 43.52K | 55.75K | 38.04K | - | 1.26K | 2.98K | 8.44K |
Goodwill & Intangibles | 8.81M | 10.74M | 8.70M | 13.21M | 5.66M | 5.68M | 5.44M | 5.44M | - | - | - | - |
Total Long-Term Assets | 8.97M | 11.00M | 9.07M | 13.35M | 5.79M | 5.80M | 5.85M | 5.58M | 58.59K | 1.19M | 133.55K | 289.71K |
Total Assets | 13.71M | 18.68M | 18.06M | 15.16M | 10.11M | 14.28M | 14.31M | 9.73M | 9.51M | 1.41M | 692.19K | 2.34M |
Account Payables | 206.26K | 1.01M | 160.62K | 434.76K | 210.29K | 63.65K | 706.09K | 1.41M | 417.70K | 565.95K | 13.69K | 109.75K |
Deferred Revenue | - | - | - | - | - | 2.69M | 12.31M | 4.22M | 1.91M | 949.46K | - | - |
Short-Term Debt | 94.14K | 211.56K | 237.69K | 260.58K | 167.85K | 4.71K | 11.21K | 12.64K | - | 3.21M | 2.03M | 34.20K |
Other Current Liabilities | 1.33M | 2.05M | 1.21M | 1.29M | 1.04M | 1.11M | 1.80M | 1.66M | 1.10M | 1.25M | 530.22K | 603.14K |
Total Current Liabilities | 1.63M | 3.27M | 1.61M | 1.77M | 1.41M | 3.86M | 14.83M | 7.31M | 3.42M | 5.02M | 2.57M | 747.08K |
Long-Term Debt | 59.82K | - | 90.57K | 313.81K | - | - | 4.86K | 16.07K | - | - | - | - |
Other Long-Term Liabilities | 5.13M | 3.31M | 3.85M | 2.55M | 1.71M | 1.21M | 1.21M | 1.21M | - | - | 36.41M | 36.41M |
Total Long-Term Liabilities | 5.97M | 4.00M | 7.22M | 6.39M | 2.08M | 1.48M | 1.40M | 2.75M | - | 36.41M | 36.41M | 36.41M |
Total Liabilities | 7.60M | 7.27M | 8.83M | 8.16M | 3.49M | 5.34M | 16.23M | 10.06M | 3.42M | 41.43M | 38.98M | 37.16M |
Total Debt | 106.89K | 105.78K | 209.41K | 362.12K | 83.93K | 4.71K | 16.07K | 28.71K | - | 3.21M | 2.03M | 34.20K |
Common Stock | 77.08K | 17.99K | 126.64K | 55.56K | 40.78K | 437.94K | 172.57K | 101.31K | 76.57K | 2.02K | 1.84K | 1.83K |
Retained Earnings | -146.98M | -134.46M | -124.73M | -108.34M | -100.25M | -93.15M | -91.82M | -78.60M | -65.26M | -56.86M | -55.09M | -51.21M |
Comprehensive Income | -182.80K | -182.74K | -86.43K | -802 | 139.47K | 134.33K | 127.47K | 120.19K | 114.79K | 56.54K | 52.92K | 39.11K |
Shareholders Equity | 6.11M | 11.41M | 9.22M | 7.00M | 6.62M | 8.94M | -1.93M | -329.42K | 6.09M | -46.81M | -44.84M | -41.16M |
Total Investments | 4.27K | 49.26K | 45.00K | 45.00K | 45.00K | 45.00K | 45.00K | 103.82K | 78.82K | - | - | - |